|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 14.50 USD | -1.83% |
|
-0.07% | -36.96% |
| 09-03 | Ionis Pharma prices first FDA-approved treatment for Alexander disease at $285,000 per dose | RE |
| 09-03 | Top Midday Decliners | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.83% | -0.07% | -45.20% | -50.43% | -36.96% | -47.88% | -60.46% | -84.75% | -80.03% | 1.45B | |
| +1.52% | -7.16% | -1.32% | +16.54% | -13.24% | +5.36% | -83.73% | -79.39% | -67.72% | 1.94B | |
| -0.54% | -0.21% | -3.53% | +4.62% | -15.08% | -21.40% | -1.48% | - | - | 342M | |
| -7.74% | +20.69% | +24.72% | +14.05% | -23.50% | -33.41% | - | - | - | 65.42M | |
| Average | -2.15% | +3.61% | -6.33% | -3.80% | -22.19% | -24.33% | -48.56% | -82.07% | -73.87% | 950.5M | |
| Weighted average by Cap. | -0.10% | -2.72% | -17.83% | -10.15% | -22.64% | -18.05% | -67.15% | -81.68% | -72.98% |
- Stock Market
- Stocks
- RARE Stock
- Sector Ultragenyx Pharmaceutical Inc.
Select your edition
All financial news and data tailored to specific country editions
